Home » Authors » Kim Coghill

Articles by Kim Coghill

Push For Public Posting Of Clinical Trial Data Continues

Sep. 10, 2004

Push For Public Posting Of Clinical Trial Data Continues

Sep. 10, 2004

Encysive Brings In $30.8M, Presents Thelin Data At ERS

Sep. 9, 2004

Encysive Brings In $30.8M, Presents Thelin Data At ERS

Sep. 9, 2004

States Angling To Control Reimportation, Stem Cells

Sep. 7, 2004

States Angling To Control Reimportation, Stem Cells

Sep. 7, 2004

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Sep. 3, 2004

Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Sep. 3, 2004

Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 9, 2025.
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
NME Digest: Q1 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...